Hepion Pharmaceuticals, Inc.

HEPA | NASDAQ | 0 Followers
$0.07 -16.93% -$0.01
Follow
Loading...

Profile

Hepion Pharmaceuticals, Inc. (HEPA) is a biotechnology company focused on the research and development of therapies for liver diseases and metabolic disorders. Headquartered in the United States, the company aims to utilize its drug candidates to treat diseases such as non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Hepion Pharmaceuticals seeks to develop innovative pharmaceutical solutions for patients with these serious health conditions. Shares of Hepion Pharmaceuticals, Inc. (HEPA), listed on the NASDAQ, can be an appealing choice for investors seeking investment opportunities in the biotechnology and liver disease treatment sector.

Feed

There are no posts to show right now.
Don't have an account? Join us

Log in to Bulios


Or use email and password
Already a member? Log in

Create Bulios profile

Continue with

Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools

Menu StockBot
Tracker
Upgrade